Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study.

[1]  Nandini Dendukuri,et al.  Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults , 2019, The Cochrane database of systematic reviews.

[2]  Kyle B. Bond,et al.  Impact of External Quality Assurance on the Quality of Xpert MTB/RIF Testing in Viet Nam , 2018, Journal of Clinical Microbiology.

[3]  L. Scott,et al.  Performance of Xpert MTB/RIF, Xpert Ultra, and Abbott RealTime MTB for Diagnosis of Pulmonary Tuberculosis in a High-HIV-Burden Setting , 2018, Journal of Clinical Microbiology.

[4]  P. V. van Helden,et al.  Diagnostic Accuracy and Utility of FluoroType MTBDR, a New Molecular Assay for Multidrug-Resistant Tuberculosis , 2018, Journal of Clinical Microbiology.

[5]  A. Garcia-Basteiro,et al.  Point of care diagnostics for tuberculosis. , 2018, Pulmonology.

[6]  J. Salomon,et al.  Tuberculosis control interventions targeted to previously treated people in a high-incidence setting: a modelling study , 2018, The Lancet. Global health.

[7]  K. Dheda,et al.  False-Positive Xpert MTB/RIF Results in Retested Patients with Previous Tuberculosis: Frequency, Profile, and Prospective Clinical Outcomes , 2018, Journal of Clinical Microbiology.

[8]  S. Dorman,et al.  Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study , 2018, The Lancet. Infectious diseases.

[9]  A. Garcia-Basteiro,et al.  The Good, the Bad and the Ugly of the Next-Generation Xpert Mtb/Rif® Ultra Test for Tuberculosis Diagnosis. , 2017, Archivos de bronconeumologia.

[10]  D. Dowdy,et al.  Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study , 2017, PLoS medicine.

[11]  C. Evans,et al.  Improving tuberculosis diagnosis: Better tests or better healthcare? , 2017, PLoS medicine.

[12]  D. Alland,et al.  The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing , 2017, mBio.

[13]  Johannes B Reitsma,et al.  STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration , 2016, BMJ Open.

[14]  L. Dodd,et al.  Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB , 2016, PloS one.

[15]  Madhukar Pai,et al.  Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better? , 2016, European Respiratory Journal.

[16]  K. Dheda,et al.  Xpert MTB/RIF Results in Patients With Previous Tuberculosis: Can We Distinguish True From False Positive Results? , 2016, Clinical Infectious Diseases.

[17]  P. V. van Helden,et al.  The temporal dynamics of relapse and reinfection tuberculosis after successful treatment: a retrospective cohort study. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  D. Dowdy,et al.  Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings? , 2014, The Lancet. Infectious diseases.

[19]  N. Dendukuri,et al.  Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults , 2014, The Cochrane database of systematic reviews.

[20]  C. Wejse,et al.  TBscore II: Refining and validating a simple clinical score for treatment monitoring of patients with pulmonary tuberculosis , 2013, Scandinavian journal of infectious diseases.

[21]  K. Dheda,et al.  Sputum induction to aid diagnosis of smear-negative or sputum-scarce tuberculosis in adults in HIV-endemic settings , 2013, European Respiratory Journal.

[22]  S. Lawn,et al.  Burden of New and Recurrent Tuberculosis in a Major South African City Stratified by Age and HIV-Status , 2011, PloS one.

[23]  D. Mitchison,et al.  Timing of relapse in short-course chemotherapy trials for tuberculosis. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[24]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[25]  E. DeLong,et al.  Intermediate, Indeterminate, and Uninterpretable Diagnostic Test Results , 1987, Medical decision making : an international journal of the Society for Medical Decision Making.

[26]  R. Urbanczik,et al.  The public health service national tuberculosis reference laboratory and the national laboratory network : minimum requirements, role and operation in a low-income country , 1998 .